1 |
Alvarez-Cedron, L., Sayalero, M. L., and Lanao, J. M., High-performance chromatographic validated assay of doxorubicin in rat plasma and tissues. J. Chromatogr. B, 721, 271-278 (1999)
DOI
ScienceOn
|
2 |
European Pharmacopoeia Commission, European Pharmacopoeia, Councilof Europe, Strasbourg, 785 (1997)
|
3 |
Korea Food and Drug Administration, The Minimum Requirements for Antibiotic Products of Korea, Yakup Shinmoon Co., Korea, 318 (2000)
|
4 |
Ricciarello, R, Pichini, S., Pacifici, R, Altieri, I., Pellegrini, M., Fattorossi, A. and Zuccaro, P., Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection. J. Chromatogr. B, 707, 219-225 (1998)
DOI
ScienceOn
|
5 |
United States Pharmacopeial Convention, U. S. Pharmacopeia & National Formulary, National Publishing, Philadelphia, PA, 606 (2000)
|
6 |
Sastry, C. S. P. and Rao, J., Determination of doxorubicin hydrochloride by visible spectrophotometry. Talanta, 43, 1827-1835 (1996)
DOI
ScienceOn
|
7 |
Hu, Q., Zhang, L., Zhou, T., and Fang, Y, Determination of daunorubicin in human urine by capillary zone electrophoresis with amperometric detection. Anal. Chim. Acta, 416, 15-19 (2000)
DOI
ScienceOn
|
8 |
Zagotto, G.,Gatto, B., Moro, S., Sissi, C., and Palumbo, M., Anthracyclines: recent developments in their separation and quantitation. J. Chromatogr. B: Biomed. Sci. Appl., 764, 161-171 (2001)
DOI
ScienceOn
|
9 |
Buehler, P W., Robles, S. J., Adami, G. R, Gajee, R, and Negrusz, A., Analysis of doxorubicin in cell culture media and human plasma using solid phase extraction and HPLC. Chromatographia, 49, 557-561 (1999)
DOI
|